Escitalopram-induced extrapyramidal symptoms
- PMID: 31142916
- PMCID: PMC6532473
- DOI: 10.4103/psychiatry.IndianJPsychiatry_331_18
Escitalopram-induced extrapyramidal symptoms
Conflict of interest statement
There are no conflicts of interest.
References
-
- Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants – A review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry. 2010;22:148–56. - PubMed
-
- Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: Implications for treatment. J Psychopharmacol. 1998;12:192–214. - PubMed
-
- Dave-Momin N, Lokhande C, Shah N, Desousa A. Escitalopram induced dystonia: A case report. Int J Toxicol Pharmacol Res. 2014;6:20–1.
-
- Hedenmalm K, Güzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol. 2006;26:192–7. - PubMed
